5 results on '"Goodman, William"'
Search Results
2. Tablet PCs and Reconceptualizing Learning with Technology: A Case Study in Higher Education
- Author
-
van Oostveen, R., Muirhead, William, and Goodman, William M.
- Abstract
Purpose: This study aims to examine the experience of 31 university students who were issued tablet PCs for their use during an academic year. The primary research problem which drove this project revolved around the student perceptions of the benefits of technology to provide opportunities to restructure their learning experiences. Design/methodology/approach: The students were surveyed twice during the year and they were invited to participate in either individual interviews or a series of focus groups. A number of lectures were also visited and observed. The survey results provided quantitative data regarding student usage of the technology. The interviews, focus groups and observed classes provided data around the reasons why the students used the technology in the ways they did. Findings: Little evidence was found to support a contention that meaningful learning with technology had occurred and, in spite of their comfort and familiarity with the technology, there is no evidence of changing attitudes with respect to meaningful learning on the part of the students surveyed in this study. Research limitations/implications: A major application of this should be directed towards similar studies focused on combining the redefinition usage potential of new touch interface-driven devices, such as the iPad, with a new pedagogical approaches to support learners to use the technology as cognitive tools. Originality/value: It is important to note that the introduction of a new technology, even if it makes a wide variety of affordances available for use, cannot by itself, instigate redefinition of learning tasks to allow for meaningful learning to occur. (Contains 1 figure and 1 table.)
- Published
- 2011
- Full Text
- View/download PDF
3. The Canadian Model.
- Author
-
Goodman, William E.
- Subjects
- *
HEALTH policy , *MEDICAL care costs - Abstract
Presents a speech by Doctor William E. Goodman, delivered at the 46th Annual Meeting of the Association of American Physicians and Surgeons in Orlando, Florida on September 21, 1989. Difference between the constitutional and political system of the U.S. and Canada; Explanation on health care costs; List of problems arising from the financial absurdity of the Canadian health care system.
- Published
- 1990
4. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
- Author
-
Sprague SM, Wetmore JB, Gurevich K, Da Roza G, Buerkert J, Reiner M, Goodman W, and Cooper K
- Subjects
- Aged, Australia, Biomarkers blood, Calcimimetic Agents adverse effects, Calcium blood, Canada, Chi-Square Distribution, Cinacalcet adverse effects, Female, Fibroblast Growth Factor-23, Humans, Hyperparathyroidism, Secondary blood, Hyperparathyroidism, Secondary diagnosis, Kidney Failure, Chronic blood, Kidney Failure, Chronic complications, Kidney Failure, Chronic diagnosis, Logistic Models, Male, Middle Aged, Parathyroid Hormone blood, Phosphorus blood, Prospective Studies, Risk Factors, Russia, Time Factors, Treatment Outcome, United States, Vitamin D adverse effects, Vitamin D analogs & derivatives, Calcimimetic Agents therapeutic use, Cinacalcet therapeutic use, Fibroblast Growth Factors blood, Hyperparathyroidism, Secondary drug therapy, Kidney Failure, Chronic therapy, Renal Dialysis adverse effects, Vitamin D therapeutic use
- Abstract
Background and Objectives: Cinacalcet and vitamin D are often combined to treat secondary hyperparathyroidism (SHPT) in patients on dialysis. Independent effects on fibroblast growth factor-23 (FGF-23) concentrations in patients on hemodialysis administered cinacalcet or vitamin D analogs as monotherapies during treatment of SHPT are evaluated., Design, Setting, Participants, & Measurements: A multicenter, randomized, open-label study to compare the efficacy of cinacalcet versus traditional vitamin D therapy for management of secondary hyperparathyroidism among subjects undergoing hemodialysis (PARADIGM) was a prospective, phase 4, multicenter, randomized, open-label study conducted globally. Participants (n=312) were randomized 1:1 to cinacalcet (n=155) or vitamin D analog (n=157) for 52 weeks. Levels of FGF-23 were measured at baseline and weeks 20 and 52. The absolute and percentage changes from baseline in plasma FGF-23, parathyroid hormone (PTH), calcium (Ca), phosphorus (P), and calcium-phosphorus product (Ca×P) were assessed. Correlations and logistic regression were used to explore relationships between changes in FGF-23 and changes in PTH, Ca, P, and Ca×P from baseline to week 52 by treatment arm., Results: Median (quartiles 1, 3) decrease in FGF-23 concentrations was observed in the cinacalcet arm (-40%; -63%, 16%) compared with median increase in the vitamin D analog arm (47%; 0%, 132%) at week 52 (P<0.001). Changes in FGF-23 in both arms were unrelated to changes in PTH (cinacalcet: r=0.17, P=0.11; vitamin D analog: r=-0.04, P=0.70). Changes in FGF-23 in the vitamin D analog but not the cinacalcet arm were correlated with changes in Ca (cinacalcet: r=0.11, P=0.30; vitamin D analog: r=0.32, P<0.01) and P (cinacalcet: r=0.19, P=0.07; vitamin D analog: r=0.49, P<0.001). Changes in FGF-23 were correlated with changes in Ca×P in both arms (cinacalcet: r=0.26, P=0.01; vitamin D analog: r=0.57, P<0.001). Independent of treatment arm, participants with reductions in P or Ca×P were significantly more likely to show reductions in FGF-23., Conclusions: During treatment of SHPT, cinacalcet use was associated with a decrease in FGF-23 concentrations, whereas vitamin D analogs were associated with an increase. The divergent effects of these treatments on FGF-23 seem to be independent of modification of PTH. It is possible that effects of cinacalcet and vitamin D analogs on FGF-23 may be mediated indirectly by other effects on bone and mineral metabolism., (Copyright © 2015 by the American Society of Nephrology.)
- Published
- 2015
- Full Text
- View/download PDF
5. Risk factors for increased severity of paediatric medication administration errors.
- Author
-
Sears K and Goodman WM
- Subjects
- Canada epidemiology, Child, Drug-Related Side Effects and Adverse Reactions etiology, Health Policy, Humans, Medication Errors adverse effects, Risk Factors, Severity of Illness Index, Medication Errors statistics & numerical data
- Abstract
Patients' risks from medication errors are widely acknowledged. Yet not all errors, if they occur, have the same risks for severe consequences. Facing resource constraints, policy makers could prioritize factors having the greatest severe-outcome risks. This study assists such prioritization by identifying work-related risk factors most clearly associated with more severe consequences. Data from three Canadian paediatric centres were collected, without identifiers, on actual or potential errors that occurred. Three hundred seventy-two errors were reported, with outcome severities ranging from time delays up to fatalities. Four factors correlated significantly with increased risk for more severe outcomes: insufficient training; overtime; precepting a student; and off-service patient. Factors' impacts on severity also vary with error class: for wrong-time errors, the factors precepting a student or working overtime significantly increase severe-outcomes risk. For other types, caring for an off-service patient has greatest severity risk. To expand such research, better standardization is needed for categorizing outcome severities., (Copyright © 2012 Longwoods Publishing.)
- Published
- 2012
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.